Lilly’s Trulicity applied for national health insurance benefit in combination with insulin
Lilly Korea(CEO Paul Henry Huibers) announced the Ministry of Health and Welfare’s national health insurance benefit standards were extensively revised under a revision bill for ‘Trulicity(generic name: dulaglutide)’ to be used with health insurance benefits in combination with insulin on the 1st...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.